Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States
PaperCitations, authors & open-access status
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 14 citations, 2024 year and hybrid oa status.
14
Citations
2024
Year
hybrid
OA Status